Offer - Urjas Oil for just ₹ 1 X
Rosulip F 5 Tablet is a prescription medicine that is available as a Tablet. Secondary and off-label uses of Rosulip F 5 Tablet have also been mentioned below.
The optimal dosage of Rosulip F 5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Common side effects of Rosulip F 5 Tablet include Nausea or vomiting, Headache, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rosulip F 5 Tablet as well, which are listed below. Normally, these side effects of Rosulip F 5 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Rosulip F 5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Rosulip F 5 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rosulip F 5 Tablet related warnings section.
Individuals suffering from medical conditions like Diabetes must refrain from the use of Rosulip F 5 Tablet since this can cause severe adverse effects.
Besides this, Rosulip F 5 Tablet may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Rosulip F 5 Tablet is not safe while driving, and is not addiction.
Rosulip F 5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosulip F 5 Tablet safe for pregnant women?
Rosulip F may have some side effects during pregnancy. Pregnant women should discontinue the use of Rosulip F, and talk to their doctor, if they notice any discomfort.
Is the use of Rosulip F 5 Tablet safe during breastfeeding?
Rosulip F may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Rosulip F, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Rosulip F.
What is the effect of Rosulip F 5 Tablet on the Kidneys?
Rosulip F may have mild side effects on the kidneys.
What is the effect of Rosulip F 5 Tablet on the Liver?
Rosulip F may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rosulip F 5 Tablet on the Heart?
The heart can be affected by Rosulip F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Rosulip F 5 Tablet unless your doctor advises you to do so -
Is this Rosulip F 5 Tablet habit forming or addictive?
Rosulip F 5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rosulip F 5 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Rosulip F 5 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Rosulip F 5 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Rosulip F 5 Tablet
There isn't any research available on the side effects of taking Rosulip F 5 Tablet with food.
Interaction between Alcohol and Rosulip F 5 Tablet
Due to lack of research, there is no information about the side effects of taking Rosulip F 5 Tablet with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650